gebhart/patrepeval huggingface dataset:
The Effect of Teriparatide [Human Parathyroid Hormone (1–34)] Therapy on Bone Density in Men With Osteoporosis (2003)

Teriparatide [rhPTH(1-34)] increases bone mineral density and reduces the risk of vertebral fracture in women. We randomized 437 men with spine or hip bone mineral density more than 2 SD below the young adult male mean to daily injections of placebo, teriparatide 20 microg, or teriparatide 40 microg. All subjects also received supplemental calcium and vitamin D. The study was stopped after a median duration of 11 months because of a finding of osteosarcomas in rats in routine toxicology studies. Biochemical markers of bone formation increased early in the course of therapy and were followed by increases in indices of osteoclastic activity. Spine bone mineral density was greater than in placebo subjects after 3 months of teriparatide therapy, and by the end of therapy it was increased by 5.9% (20 microg) and 9.0% (40 microg) above baseline (p < 0.001 vs. placebo for both comparisons). Femoral neck bone mineral density increased 1.5% (20 microg; p = 0.029) and 2.9% (40 microg; p < 0.001), and whole body bone mineral content increased 0.6% (20 microg; p = 0.021) and 0.9% (40 microg;p = 0.005) above baseline in the teriparatide subjects. There was no change in radial bone mineral density in the teriparatide groups. Bone mineral density responses to teriparatide were similar regardless of gonadal status, age, baseline bone mineral density, body mass index, smoking, or alcohol intake. Subjects experienced expected changes in mineral metabolism. Adverse events were similar in the placebo and 20-microg groups, but more frequent in the 40-microg group. This study shows that teriparatide treatment results in an increase in bone mineral density and is a potentially useful therapy for osteoporosis in men.
Modification of polymers with UV excimer radiation from lasers and lamps (1994)

Photochemical dry etching and surface modification of various polymers, e.g. polymethylmethacrylate (PMMA), polyimide (PI), polyethyleneterephthalate (PET) and polytetrafluoroethylene (PTFE) were investigated with coherent and incoherent excimer UV sources. Ablation rates of PMMA were measured as a function of laser fluence and laser pulse at the wavelength λ = 248 nm (KrF*). Decomposition and etch rates of PMMA and PI were determined as a function of UV intensity and exposure time at three different wavelengths λ = 172 nm (Xe*2), λ = 222 nm (KrCl*) and λ = 308 nm (XeCl*). The transmittance of the polymeric films was determined with a UV-spectrophotometer after different exposure times. The morphology of the exposed polymers was investigated with scanning electron microscopy (SEM). The gaseous products occurring during UV exposure were measured using mass spectrometry (MS). Chemical surface changes of the photoetched PMMA were determined by X-ray photoelectron spectroscopy (XPS). The mechanism of the photo-oxidation process of PMMA is discussed. The etching of PMMA can be explained as a result of extensive photo-oxidation. The results are compared with those obtained from mercury lamp and excimer laser experiments. Good adhesion of electrolessly deposited metal layers was achieved by irradiation of the polymeric surfaces from incoherent UV source before depositing the metal layer.
Coalescence in Surfactant-Stabilized Double Emulsions (2001)

In this paper, we investigate the two mechanisms that are responsible for the release of a chemical substance from water-in-oil-in-water double emulsions. (i) One is due to the coalescence of the thin liquid film separating the internal droplets and the oil globule surface. (ii) The other mechanism occurs without film rupturing, that is, by diffusion and/or permeation of the chemical substance across the oil phase. The thin liquid film that forms between the internal droplets and the globule surface is composed of two mixed monolayers covered by hydrophilic and hydrophobic surfactant molecules. Following the well-known Bancroft rule, such inverted films possess a long-range stability with respect to coalescence when essentially covered by hydrophobic surfactant. In that limit, the release is governed by diffusion and/or permeation. However, the film becomes very unstable when a strong proportion of hydrophilic surfactant is adsorbed and the release is then controlled by coalescence. We show that the transition from one regime (diffusion) to the other (coalescence) may be achieved by varying the concentration of the hydrophilic surfactant in the external water phase. We study the kinetics of release in the regime dominated by coalescence, and we propose an unambiguous method for the measurement of the microscopic parameters implied in liquid film rupturing. Our method exploits the fact that the total number of internal droplets adsorbed on the globule surface governs the rate of release. At low internal droplet volume fraction, measuring the rate of release allows a direct determination of the average lifetime of the thin film that forms between the small internal droplet and the globule surface. We deduce the activation energy and the natural frequency of the coalescence process by exploring the temperature dependence of the rate of release.
Nitric oxide release from a biodegradable cysteine-based polyphosphazene (2016)

Nitric oxide (NO) is a unique bioactive molecule that performs multiple physiological functions and has been found to exhibit antithrombotic, antimicrobial, and wound-healing effects as an exogenous therapeutic agent. NO release from polymeric materials intended for use in biomedical applications has been established to reduce their thrombogenicity and decrease the likelihood of infection and inflammation that frequently produce medical complications. As a result, numerous NO-releasing polymers have been developed in an effort to utilize the beneficial properties of NO to improve the performance of implantable materials. The majority of synthetic NO-releasing biodegradable polymers that have been reported to date are polyesters, and there is significant interest in the development of new NO-releasing materials with improved or distinctive physicochemical characteristics. Polyphosphazenes are polymers with inorganic phosphorus-nitrogen backbones, and hydrolytically-sensitive derivatives with organic substituents have been prepared that degrade under physiological conditions. For this reason, biodegradable poly(organophosphazenes) are interesting candidate materials for applications such as tissue engineering, where the addition of NO release capability may be therapeutically useful. Herein, we report the first development and characterization of an NO-releasing poly(organophosphazene) from poly(ethyl S-methylthiocysteinyl-co-ethyl cysteinyl phosphazene) (POP-EtCys-SH). The thiolated polymer was synthesized from the reaction of poly(dichlorophosphazene) with ethyl S-methylthiocysteinate, followed by partial cleavage of the disulfide linkages to form free thiol groups. The conversion of thiol to the NO-releasing S-nitrosothiol functional group with tert-butyl nitrite resulted in a polymer (POP-EtCys-NO) with an average NO content of 0.55 ± 0.04 mmol g<sup>-1</sup> that was found to release a total of 0.35 ± 0.02 mmol NO g<sup>-1</sup> over 24 h under physiological conditions (37 °C, pH 7.4 phosphate buffered saline). Extracts obtained from both the thiolated and S-nitrosated polymers were not found to significantly impair the viability of human dermal fibroblasts or induce morphological changes, indicating that this cysteine-based polyphosphazene may possess potential utility as an NO-releasing biomaterial.
Increased production of low molecular weight recombinant proteins in Escherichia coli (1997)

A general method for obtaining high-level production of low molecular weight proteins in Escherichia coli is described. This method is based on the use of a novel Met-Xaa-protein construction which is formed by insertion of a single amino acid residue (preferably Arginine or Lysine) between the N-terminal methionine and the protein of interest. The utility of this method is illustrated by examples for achieving high-level production of human insulin-like growth factor-1, human proinsulin, and their analogs. Furthermore, highly produced insulin-like growth factor-1 derivatives and human proinsulin analogs are converted to their natural sequences by removal of dipeptides with cathepsin C.
All-trans-Retinoic Acid-mediated Growth Inhibition Involves Inhibition of Human Kinesin-related Protein HsEg5 (1999)

In this study we used differential display reverse transcription-polymerase chain reaction to search for differentially expressed all-trans-retinoic acid (ATRA)-responsive genes in pancreatic carcinoma cells. We identified the kinesin-related protein HsEg5, which plays an essential role in spindle assembly and spindle function during mitosis, as a novel molecule involved in ATRA-mediated growth inhibition. Using Northern and Western blot analysis we demonstrated that ATRA significantly inhibits HsEg5 expression in various pancreatic carcinoma cell lines as well as in HaCat keratinocytes. Inhibition of HsEg5 expression by ATRA occurs at the posttranscriptional level. As a consequence, tumor cells synchronized in S-phase revealed a retarded progression through G2/M phase of the cell cycle indicating that HsEg5 inhibition results in a delayed progression through mitosis. Furthermore, a significant decrease of HsEg5 protein expression achieved by antisense transfection revealed a significant growth inhibition compared with control cells. Therefore, HsEg5 represents a novel molecule involved in ATRA-mediated growth inhibition, suggesting that vitamin A derivatives can interact with the bipolar spindle apparatus during mitosis.
In vitro and in vivo behaviour of narciclasine released from matrices based on poly (2-hydroxyethyl methacrylate). (1991)

Narciclasine (1,2,3,7-tetrahydroxy-8,9-methylendioxy-1,2,3,4-tetrahydrophena ntridone) is a natural substance with strong antimitotic effects on cells and potential antitumor activity. Its release form a hydrogel matrix was studied with the purpose of avoiding the concentration spikes of the parenteral administration. The matrix prepared by gamma ray polymerization of a mixture of 2-hydroxyethyl methacrylate (85%) and trimethylolpropane trimethacrylate (15%) was found to release narciclasine for several days, according to a diffusion controlled mechanism. In agreement with its antimitotic effect, narciclasine inhibited the growth rate of healthy mice, when the drug-loaded matrix was introduced subcutaneously. Antitumor effect was observed in an experimental model of Erlich ascitic tumor when low amounts of tumor cells were inoculated. No effect was observed at high concentrations of inoculum or towards solid tumors (Sarcoma 180). This behaviour was related to the rapid clearance of narciclasine from the body which prevented the reaching of sufficient therapeutical concentrations. A pharmacokinetic investigation carried out by an original method of assay demonstrated that narciclasine was accumulated in significant amounts in the kidney only and eliminated in urine with a half time of less than 20 min.
Distribution of the voltage‐gated sodium channel Nav1.7 in the rat: Expression in the autonomic and endocrine systems (2007)

It is generally accepted that the voltage-gated, tetrodotoxin-sensitive sodium channel, Na(V)1.7, is selectively expressed in peripheral ganglia. However, global deletion in mice of Na(V)1.7 leads to death shortly after birth (Nassar et al. [2004] Proc. Natl. Acad. Sci. U. S. A. 101:12706-12711), suggesting that this ion channel might be more widely expressed. To understand better the potential physiological function of this ion channel, we examined Na(V)1.7 expression in the rat by in situ hybridization and immunohistochemistry. As expected, highest mRNA expression levels are found in peripheral ganglia, and the protein is expressed within these ganglion cells and on the projections of these neurons in the central nervous system. Importantly, we found that Na(V)1.7 is present in discrete rat brain regions, and the unique distribution pattern implies a central involvement in endocrine and autonomic systems as well as analgesia. In addition, Na(V)1.7 expression was detected in the pituitary and adrenal glands. These results indicate that Na(V)1.7 is not only involved in the processing of sensory information but also participates in the regulation of autonomic and endocrine systems; more specifically, it could be implicated in such vital functions as fluid homeostasis and cardiovascular control.
Fluid-Loss Control Improves Performance of Viscoelastic Surfactant Fluids (2009)

Summary Viscoelastic surfactant (VES) fluids have been widely used as gravel-packing, frac-packing and fracturing fluids for more than a decade because the fluids exhibit excellent rheological properties and maintain low formation-damage characteristics compared with crosslinked-polymer fluids (Nehmer, 1988; Brown et al. 1996). Because of its non-wall-building property, VES fluid has much higher fluid leakoff into the reservoir matrix than wall-building polymer fluid. For frac-packing, this high-leakoff property has limited VES fluid's application to reservoirs with permeability of less than 400 md. Excessive fluid leakoff also significantly increases the cost of treatment. This paper will introduce new technology for controlling the fluid loss of VES fluids to approximately 300°F. New fluid-loss control agents have been developed that, through chemisorption and surface-charge attraction, associate with VES micelles to produce a pseudo-filter-cake of viscous VES fluid that significantly reduces the rate of fluid loss. Use of this technology will reduce the VES fluid volume required for a given treatment by up to two-thirds and extends the permeability range of VES fluids to approximately 2000 md. The fluid-loss control agents are tiny particles that are used at relatively low concentrations. The tiny particles will be flowed back with the production fluid after VES micelles are broken by internal breakers. The rate of the pseudo-filter-cake cleanup is enhanced by use of internal VES breakers. The results of rheology, leak-off, and core flow tests will be presented for the VES fluid systems at temperatures 150°F and 250°F.
Transforming growth factor-beta stimulates trophoblast oncofetal fibronectin synthesis in vitro: implications for trophoblast implantation in vivo. (1994)

In pregnancy tissues, oncofetal fibronectin (onfFN) has been localized specifically to the extracellular matrix (ECM) surrounding extravillous anchoring trophoblasts of the placental-uterine junction and chorion. When isolated from first or third trimester placentas, human cytotrophoblasts in culture secrete and deposit onfFN in the ECM. In addition, onfFN synthesis is significantly up-regulated in response to serum stimulatory factor(s). The goal of this study was to examine the role of transforming growth factor-beta (TGF beta), a cytokine present in uterine decidua, as a stimulator of trophoblast onfFN production. Our initial insight into the significance of TGF beta resulted from the serendipitous use of cord serum from a neonate with severe alloimmune thrombocytopenia. Trophoblasts cultured in medium containing this serum underwent normal morphological differentiation, but produced markedly less onfFN. In an analogous fashion, trophoblasts cultured in normal serum preincubated with anti-TGF beta neutralizing antibodies also produced significantly less onfFN. Exogenously added TGF beta 1 restored the ability of trophoblasts to produce onfFN by a factor of 4- to 5-fold in medium containing thrombocytopenic serum. In platelet-poor serum derived from human or bovine plasma, TGF beta 1 also induced onfFN synthesis, as assayed both in the conditioned medium and by immunocytochemical localization of onfFN in cell-associated ECM fibrils. Dose-response analysis demonstrated that the onfFN stimulatory response is sensitive to TGF beta, with an ED50 of 0.1-0.2 ng/ml. In a reciprocal fashion, TGF beta inhibited beta hCG secretion 3- to 4-fold. Our results demonstrate that TGF beta is a significant stimulator of trophoblast onfFN production. Furthermore, TGF beta appears to modulate trophoblast differentiation by up-regulating the expression of an anchoring trophoblast marker (onfFN) and down-regulating a phenotypic marker of villous syncytiotrophoblast (hCG beta). We speculate that trophoblast responsiveness to TGF beta in the implantation milieu contributes to trophoblast adhesion by stimulating the production of a trophoblast-derived implantation site fibronectin.
Generation and Analysis of Siah2 Mutant Mice (2003)

Siah proteins function as E3 ubiquitin ligase enzymes to target the degradation of diverse protein substrates. To characterize the physiological roles of Siah2, we have generated and analyzed Siah2 mutant mice. In contrast to Siah1a knockout mice, which are growth retarded and exhibit defects in spermatogenesis, Siah2 mutant mice are fertile and largely phenotypically normal. While previous studies implicate Siah2 in the regulation of TRAF2, Vav1, OBF-1, and DCC, we find that a variety of responses mediated by these proteins are unaffected by loss of Siah2. However, we have identified an expansion of myeloid progenitor cells in the bone marrow of Siah2 mutant mice. Consistent with this, we show that Siah2 mutant bone marrow produces more osteoclasts in vitro than wild-type bone marrow. The observation that combined Siah2 and Siah1a mutation causes embryonic and neonatal lethality demonstrates that the highly homologous Siah proteins have partially overlapping functions in vivo.
Effectiveness of itraconazole on clinical symptoms and radiologic findings in patients with recurrent chronic rhinosinusitis and nasal polyposis (2014)

This study showed the beneficial effect of 3-month itraconazole treatment on clinical symptoms and radiologic findings and QoL in patients with recurrent postsurgical chronic rhinosinusitis and nasal polyposis.
Herpes simplex virus immediate-early promoters are responsive to virus and cell trans-acting factors (1987)

The promoters for each of the immediate-early genes from herpes simplex virus type 1 were cloned and fused to a chloramphenicol acetyltransferase cassette. These chimeric genes were used as targets in a transient expression assay to determine how the immediate-early gene products ICP4 and ICP0 and the virion-associated stimulatory protein Vmw65 affected their expression in HeLa and Vero cells. The basal level of expression from these cassettes differed significantly depending on the extent of 5'-flanking sequence and the cell line that served as host. The promoters from IE-4 and IE-0 behaved in a qualitatively similar fashion independent of the host cell. However, the promoter for ICP27 had a unique response pattern: in Vero cells it acted as an alpha gene promoter, whereas in HeLa cells its response was more like that of a beta gene promoter. The promoter sequences for ICP22 and ICP47 behaved as the IE-4 and IE-0 promoters did in HeLa cells, but their response to the effector molecules in Vero cells was unlike that of other alpha gene promoters we have studied. Evidence is also presented for a role for ICP27 in autoregulation.
Metazooplankton community structure, feeding rate estimates, and hydrography in a meltwater-influenced Greenlandic fjord (2011)

In order to assess the potential responses of Greenland's coastal ecosystems to future climate change, we studied the hydrography and distribution of metazooplankton, along a transect from the slope waters beyond Fyllas Banke to the inner part of Godthbsfjord, West Greenland, in July and August 2008, and estimated feeding rates for some of the larger species groups. Within the 4 regional domains that were covered in the study (continental slope, continental shelf, outer sill region, and main fjord basin), salty coastal water and glacial runoff mixed to various extents, and 7 water masses with specific characteristics were identified. The common large copepod species were Calanus finmarchicus, C. glacialis, C. hyperboreus, and Metridia longa. Small copepod genera included Microsetella, Pseudocalanus, and Oithona, while rotifers and gastropods (primarily pteropods) were also found in high abundance. Species could be linked to the specific water masses, e.g. Calanus spp. were primarily associated with oceanic or coastal waters, whereas M. longa, Microsetella sp., Pseudocalanus sp., and rotifers were mostly found inside the fjord. The combined biomass of the large zooplankton species (5.5 10 3 mg C m -2 ) was less than that of the small species (6.8 10 3 mg C m -2 ) averaged across all sampled stations along the transect. Estimated in situ grazing rates for the large copepod species were <10% of their maximum rates, indicating food limitation. The major predatory zooplankton groups, Pareuchaeta norvegica and chaetognaths, had estimated predation effects of <1% d -1 on the prey community. The dominance of small zooplankton species within the fjord contradicts the traditional emphasis on large, lipid-rich zooplankton species in the arctic seas, and suggests that the planktonic food web structure inside the glacial fjord was different from that of the system outside.
Gender Differences in Ischemic Heart Disease (2009)

Coronary artery disease (CAD) is a leading cause of mortality and morbidity in most developed countries. Gender-related differences have been found in the presentation, prevalence, and clinical outcomes of CAD in many studies. Compared to women, men present with ST-segment elevation myocardial infarction more often and have a higher prevalence of CAD. These findings indicate that gender may have an important influence on CAD. Appropriate diagnosis, prevention, recent patent inventions, and treatment will improve the care of all patients. It is therefore necessary to consider the differences in the features of ischemic heart disease between men and women when examining patients. Novel drugs for tailor-made therapy based on gender differences should be developed for the treatment of CAD in future.
The Value of Routine Serum Carcino-Embryonic Antigen Measurement and Computed Tomography in the Surveillance of Patients After Adjuvant Chemotherapy for Colorectal Cancer (2004)

Surveillance CT and CEA are valuable components of postoperative follow-up in stage II and III colorectal cancer.
Ladder-Type Oligo-p-phenylene-Containing Copolymers with High Open-Circuit Voltages and Ambient Photovoltaic Activity (2010)

Four ladder-type oligo-p-phenylene containing donor-acceptor copolymers were designed, synthesized, and characterized. The ladder-type oligo-p-phenylene was used as an electron donor unit in these copolymers to provide a deeper highest occupied molecular orbital (HOMO) level for obtaining polymer solar cells with a higher open-circuit voltage, while 4,7-dithien-2-yl-2,1,3-benzothiadiazole or 5,8-dithien-2-yl-2,3-diphenylquinoxaline was chosen as an electron acceptor unit to tune the electronic band gaps of the polymers for a better light harvesting ability. These copolymers exhibit field-effect mobilities as high as 0.011 cm(2)/(V s). Compared to fluorene containing copolymers with the same acceptor unit, these ladder-type oligo-p-phenylene containing copolymers have enhanced and bathochromically shifted absorption bands and much better solubility in organic solvents. Photovoltaic applications of these polymers as light-harvesting and hole-conducting materials are investigated in conjunction with [6,6]-phenyl-C61-butyric acid methyl ester (PC(61)BM) or [6,6]-phenyl-C71-butyric acid methyl ester (PC(71)BM). Without extensive optimization work, a power conversion efficiency (PCE) of 3.7% and a high open-circuit voltage of 1.06 V are obtained under simulated solar light AM 1.5 G (100 mW/cm(2)) from a solar cell with an active layer containing 20 wt % ladder-type tetra-p-phenylene containing copolymer (P3FTBT6) and 80 wt % PC(61)BM. Moreover, a high PCE of 4.5% was also achieved from a solar cell with an active layer containing 20 wt % P3FTBT6 and 80 wt % PC(71)BM.